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HyperplasiaAbstract Background: Breast cancer is the most common cancer and a major cause of death in
women, makes up about one-tenth of all new cancer diagnoses worldwide. Breast cancer and other
cancer forms are heterogeneous diseases with varied morphological appearances, molecular fea-
tures, behavior, and response to therapies (using surgery, chemotherapy, radiation therapy and tar-
geted therapy). Despite the achievement of objective responses, the available treatments are
associated with signiﬁcant limitations in safety and efﬁcacy. Several plant products (barks, leaves,
ﬂowers, roots, fruits, seeds) have been characterized as effective in cancer chemoprevention with
minimal or no side effects.
Aims: This study is aimed at evaluating the antiproliferative potential of aqueous leaf extract of
Mucuna pruriens on 7,12-dimethylbenzeneanthracene (DMBA)-induced-breast cancer in female
albino rats.
Materials and methods: M. pruriens, thirty (30) female albino rats and
7,12-dimethylbenzeneanthracene were used for this study. Hot extraction protocol was employed
in the preparation of aqueous extract of M. pruriens leaves. Qualitative and quantitative phyto-
chemical screening of aqueous leaf extract of M. pruriens and weight determination was employed
using standard protocol. Comet assay protocol was employed to determine level of deoxyribonu-
cleic acid (DNA) fragmentation while hematoxylin and eosin were used for histological assay.
Results: Phytochemical screening revealed the presence of alkaloids, reducing sugar, anthraqui-
nones, ﬂavonoids, saponins, tannins, cardiac glycosides, phenols and steroids. Flavonoid was quan-
titatively determined to be present in the highest amount. Histological assay revealed the presenceDNA,
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332 J.B. Minari et al.of atrophy of seromucous glands with surrounding stromal ﬁbrosis and hyperplasia of serous and
mucinous. There was a signiﬁcant weight difference between the control and treatment groups.
Determination of length and weight of isolated tumor from rat induced with DMBA only was
2.4 cm and 2.8 g respectively. DNA smears obtained from single cell gel electrophoresis (SCGE)
suggested possible DMBA-induced damage which was signiﬁcantly prevented owing to the effect
of the leaf extract of M. pruriens.
Conclusion: This study has shown that the leaf extract ofM. pruriens could be used as a prophy-
lactic measure against DMBA-induced cell proliferation in the breast tissues of female albino rats.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cancer is a cellular disease and mainly caused by the misbal-
ance of the normal cellular growth maturation and multiplica-
tion [1]. Several chemicals and environmental toxins are
responsible for changes in normal cellular DNA. Substances
that cause DNA mutations are known as mutagens, and muta-
gens that cause cancers are known as carcinogens [2]. The most
common types of cancer in males are lung cancer, prostate
cancer, colorectal cancer, and stomach cancer, and in females,
the most common types are breast cancer, colorectal cancer,
lung cancer, and cervical cancer [3]. Breast cancer remains a
major cause of death in the United States as well as the rest
of the world [4]. Breast cancer is the most common malignancy
affecting women in many parts of the world with an estimated
1.67 million new cancer cases diagnosed in 2012 (25% of all
cancers). Breast cancer is the most frequent cause of cancer
death in women in less developed regions (324,000 deaths,
14.3% of total), it is now the second cause of cancer deaths
in more developed regions (198,000 deaths, 15.4%) after lung
cancer [5]. In Nigeria, breast cancer is the most common can-
cer seen among women [6]. Breast cancer has recently over-
taken cervical cancer as the most common female
malignancy in Western and Eastern Nigeria. It is characterized
by high mortality, younger age distribution, more advanced
stage distribution and increased frequency of high-grade
tumors, as found in African–American women [6–8]. Carcino-
genesis involves uncontrolled cell growth, which follows the
activation of oncogenes and/or the deactivation of tumor sup-
pression genes. Development and progression of breast tumors
involve a complex series of events, including dysregulation of
cellular differentiation, excessive proliferation and resistance
to apoptosis [9,10]. In those who have been diagnosed with
cancer, a number of treatments may be used, including sur-
gery, radiation therapy, chemotherapy, and targeted therapy
[11]. Breast cancer is usually treated with surgery, which may
be followed by chemotherapy or radiation therapy, or both
[12,13]. Despite the achievement of objective responses, the
available treatments are associated with signiﬁcant limitations
in safety and efﬁcacy [14,15]. In view of the limited treatment
options for patients with advanced breast cancer, preventive
and novel therapeutic approaches play an important role in
combating this disease [4,16]. The advent of modern drug-
targeted therapies has undeniably improved cancer patients’
cares. However, advanced metastasized cancer remains
untreatable. Hence, continued searching for a safer and more
effective chemoprevention and treatment is clearly needed for
the improvement of the efﬁciency and to lower the treatmentcost for cancer care [17]. In recent years the incidence of breast
cancer has increased almost everywhere. Alternatives to ther-
apy need to be developed for breast cancer control. Toward
this end, chemoprevention constitutes a valuable approach.
Cancer chemoprevention by phytochemicals may be one of
the most feasible approaches for cancer control. It is manda-
tory to expand our efforts in identifying synthetic or naturally
occurring agents that can inhibit the preneoplastic events pre-
ceding the occurrence of clinically detectable cancers [17–19].
In 1976, Sporn deﬁned chemoprevention as ‘‘the use of phar-
macologic or natural agents that inhibit the development of
invasive breast cancer either by blocking the DNA damage
that initiates carcinogenesis, or by arresting or reversing the
progression of premalignant cells in which such damage has
already occurred”. The success of several recent clinical trials
in preventive settings in selected high-risk populations suggests
that chemoprevention is a rational and appealing strategy
[20,21].
The use of plants whether herbs, shrubs or trees on parts or
whole in the treatment and management of diseases and disor-
ders date back to prehistoric days [22]. A medicinal plant as
deﬁned by the World Health Organization (WHO), is a plant
which one or more parts of it contain substances that can be
used for therapeutic purposes or which are precursors for the
synthesis of useful drugs [23]. The plant kingdom is a treasure
house of potential drugs and in recent years there has been an
increasing awareness about the importance of medicinal
plants. Drugs from the plants are easily available, less expen-
sive, safe, and efﬁcient and rarely have side effects. The plants
which have been selected for medicinal use over thousands of
years constitute the most obvious choice in the current search
for therapeutically effective new drugs such as anticancer
drugs, antimicrobial drugs, antihepatotoxic compounds [24].
Levy [25]; Van den Bogaard and Stobberingh [26] and Smolin-
ski et al. [27] asserted that medicinal plants are increasingly
gaining acceptance even among the literates in urban settle-
ments, probably due to the increasing inefﬁcacy of many mod-
ern drugs used for the control of many infections such as
typhoid fever, gonorrhea, and tuberculosis as well as and the
increasing cost of prescription drugs, for the maintenance of
personal health. Arunkumar and Muthuselvam [28] in their
study corroborate the reports of the World Health Organiza-
tion (WHO) that medicinal plants would be the best source
to obtain a variety of drugs. About 80% of individuals from
developed countries use traditional medicines, which have
compounds derived from medicinal plants. However, such
plants should be investigated to better understand their prop-
erties, safety, and efﬁciency.
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monly known as cowage plant. It is a popular Indian medicinal
plant, which has long been used in the Ayurvedic system of
medicine. All parts of M. pruriens possess valuable medicinal
properties. Roots, leaves and seeds of the plant are commonly
used in the treatment of impotence, diabetes mellitus and
cancer [29]. M. pruriens is used extensively for its
medicinal value for the treatment of diabetes mellitus in
Nigeria [30].
The overall aim of this research was to determine the
antiproliferative properties of aqueous leaf extract ofM. prur-
iens and its effect based on selected biochemical and molecular
indices such as phytochemical screening, histopathology and
DNA fragmentation in order to determine the efﬁciency of this
extract in the treatment of breast cancer in human.2. Materials and methods
2.1. Plant material
A sample of fresh leaves of M. pruriens were collected within
the Botanical Garden, University of Lagos, Lagos in the
month of August, 2014. The plant was identiﬁed and authen-
ticated by a taxonomist (Herbarium unit of Botany Depart-
ment), UNILAG, Lagos where a voucher specimen number
(LUH 6235) was deposited.
2.2. Chemicals used
7,12-Dimethylbenz(a)anthracene (DMBA) was purchased
from (Sigma Aldrich, Germany), Low Melting Point Agarose
(LMPA), Ficol and histopaque 1077. All other chemicals and
drugs used were obtained commercially and of analytical
grade.3. Methodology
3.1. Preparation of plant extract and extraction
The fresh leaves were dried under shade and then ground into
ﬁne powder using laboratory mortar and pestle. The aqueous
extracts of the plant were obtained using the Hot Extraction
Method as described by Yadav and Agarwala [24].
3.2. Tumor induction
Mammary gland tumors were induced by a freshly prepared
single dose of 20 mg of DMBA diluted in soy oil (5 mL) given
intragastrically by gavage method as described by Alfredo
et al. [31]. All the 30 female albino rats, with an average weight
of 182.9 g (161–213 g), received the chemical carcinogen at the
age of 57 days. The susceptibility of the mammary gland to
DMBA carcinogenesis is strongly age-dependent, being
maximal when the drug is administered to rats between the
ages of 45 and 60 days, which is the age of the beginning of
sexual maturity [32]. The animals were bred in our laboratory
under ideal conditions of temperature, humidity, and light,
and they were fed with appropriate ration in pellets and ﬁltered
water.3.3. Experimental design
Animals (30 female Sprague–Dawley albino rats) with average
weight of 45–66 g were classiﬁed into 6 groups, of 5 animals
each. The groups are as follows:
Group NC (Negative control) – DMBA induced rats only.
Group PC (Positive control) – Control experiment.
Group WA – DMBA induced rats treated with M. pruriens
extract (50 mg/g b wt).
Group WB – DMBA induced rats treated with M. pruriens
extract (100 mg/g b wt).
Group WC – DMBA induced rats treated with M. pruriens
extract (200 mg/g b wt).
Group WD – DMBA induced rats treated with M. pruriens
extract (300 mg/g b wt).
3.4. Plant extract administration and treatment
Rats were palpated weekly to check for tumor appearance
(tumor not really detected in the DMBA induced rats only
but recorded a total of 3 mortalities in the group). After induc-
tion with DMBA, group WA, WB, WC and WD were admin-
istered and treated with daily weekly doses of (50, 100, 200 and
300) mg/kg body-weight of the plant extract of M. pruriens
leaves by the gavage method for a period of 10 weeks respec-
tively with respect to the LD50 result of Bhaskar and Vidhya
[33].
3.5. Experimental site
The work was carried out in the animal house (Botanical
Garden), University of Lagos, Lagos in accordance with the
Code of Ethics of the World Medical Association (Declaration
of Helsinki) for animal experiment with consent from the
University of Lagos Ethics Committee guidelines for experi-
ment with whole animals.
3.6. Phytochemical screening of the plant extract
Preliminary phytochemical screening (Qualitative and Quanti-
tative analysis) of the aqueous leaf extract of M. pruriens was
carried out by methods of analysis described by Sofowara [34]
and Horborne [35].
3.7. Histological determination
For microscopic evaluation, mammary gland tissues were ﬁxed
in a ﬁxative (10% formal saline) and embedded in parafﬁn,
sectioned at 4–5 lm and subsequently stained with hema-
toxylin/eosin. Sections were studied under the light microscope
at 40 and 100 magniﬁcations. Slides of all the treated groups
were studied and photographed.
3.8. Comet assay
The single cell gel electrophoresis protocol used for this study
was a modiﬁed procedure of Ostling and Johanson [36]; Singh
et al. [37]; Collins [38]. Brieﬂy, Preparation of base slides was
Table 2 Result showing quantitative analysis of aqueous
extract of Mucuna pruriens leaves.
S. No. Phytochemical components % composition
1 Tannin 0.72 ± 0.008
2 Alkaloid 0.35 ± 0.006
3 Flavonoid 21.14 ± 0.013
4 Phenol 2.21 ± 0.006
5 Cardiac glycosides 13.32 ± 0.017
6 Saponin 5.06 ± 0.009
Mean values (%) of phytochemical screening of Mucuna pruriens
leaves showing mean ± SEM.
Plate 1 DMBA induced-breast cancer at the neck region of rats
treated with DMBA only. Arrows indicate the location of DMBA
334 J.B. Minari et al.done using 1% (500 mg per 50 ml PBS) and 0.5% LMPA
(250 mg per 50 ml PBS) and 1.0% NMA (500 mg per 50 ml
in Milli Q water). To the coated slide, add 75 lL of LMPA
(0.5%; 37 C) mixed with 10,000 isolated lymphocytes in
5–10 lL. Electrophoresis of Microgel Slides was done under
pH > 13 alkaline conditions, 24 V (0.74 V/cm), 300 mA for
30 min. For visualization of DNA damage, observations are
made of Silver-stained DNA using a 40 objective on a light
microscope.
3.9. Statistical analysis
Statistical analysis of data was assessed by a One-way Analysis
of Variance (ANOVA) using the GraphPad Prism software
package 5.0 for windows from Graphpad Software Inc. New-
man–Keuls Multiple Comparison Test was used to determine
the group which showed the most signiﬁcant reduction in
weight as shown in the appendix.
Results were expressed as the mean ± SEM for the 5 rats in
each group. Values of p< 0.05 were considered statistically
signiﬁcant.
4. Results
Results obtained for the qualitative phytochemical screening
of the aqueous leaf extract ofM. pruriens are shown in Table 1.
The phytochemical screening revealed that alkaloids, reducing
sugar, anthraquinones, ﬂavonoids, saponins, tannins, cardiac
glycosides, phenols and steroids were present while only ter-
penoid was absent. The quantitative phytochemical analysis
of selected phytochemicals present in the aqueous extract of
M. pruriens is shown in Table 2. Flavonoid was found to be
present in the highest amount (21.14%) while alkaloid was
found to be in the lowest amount (0.35%).
Plate 1 is an image showing 7,12-dimethylbenz(a)an-
thracene (DMBA) induced-breast cancer in an experimental
rat. DMBA induced-breast cancer was seen at the neck region
of one of the rats that received the DMBA only. This occurred
10 weeks after the administration of the carcinogen.
Table 3 shows the effect of different concentrations of aque-
ous extract ofM. pruriens on absolute increase and variation in
body weight of female albino rats administered with 7,12-Table 1 Result showing qualitative analysis of aqueous
extract of Mucuna pruriens leaves.
S. No. Phytochemical components Aqueous extract of
Mucuna pruriens leaves
1 Alkaloids +
2 Reducing sugar +
3 Anthraquinones +
4 Terpenoids 
5 Flavonoids +
6 Saponins +
7 Tannins +
8 Cardiac glycosides +
9 Phenol +
10 Steroids +
Key: (+) Presence of phytochemical(s).
() Absence of phytochemical(s).
induced papilloma.dimethylbenz(a)anthracene. There was a signiﬁcant reduction
(p< 0.05) in the weight of rats that received 300 mg/g b wt
dose of the extract when compared with those that took nei-
ther the extract nor DMBA (positive control) within the ﬁrst
3 weeks. Animals that received DMBA only (negative control)
showed a signiﬁcant increase in weight (p> 0.05) within the
10th week. However, there was decrease in weight, sickling
signs and weakness observed the ﬁrst 3 weeks after DMBA
administration.
The effects of aqueous leaf extract ofM. pruriens on the sur-
vival rate of rat induced with breast cancer using DMBA is
also shown in Fig. 1. Death was recorded in the NC (Negative
control) group after 2 weeks of DMBA administration and no
death occurrence as recorded in other groups throughout this
experiment. The highest number of deaths was recorded in NC
in the sixth week.
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Antiproliferative potential of Mucuna pruriens on DMBA-induced breast cancer 335Plate 2 showed the actual length of isolated tumor of
DMBA-induced rats only, it measured as 2.4 cm. Plate 2
showed the weight of isolated tumor of DMBA-induced rats
only which was given as 2.8 g.
Histological section of the breast tissue of experimental rats
from the positive control (PC) is shown in Plate 3. This
revealed the presence of normocellular serous glands at (HE-
100) magniﬁcation. Plate 4 shows the histological section
of the breast tissue of DMBA induced-breast cancer in rats
from negative control (NC). This revealed the presence of atro-
phy of seromucous glands with surrounding stromal ﬁbrosis
(Fibroadenoma). The histological section of the breast tissue
of DMBA induced-breast cancer in rats treated with 50 mg/
g b wt of aqueous leaf extract ofM. pruriens is shown in Plate
5. This reveals the presence of hyperplasia of serous and muci-
nous glands while the presence of DMBA-induced atrophy of
glands with periductal stromal ﬁbrosis and fatty tissue were
identiﬁed in Plate 6.
The histological section of the breast tissue of DMBA
induced-breast cancer in rats administered with 200 mg/g b wt
of aqueous leaf extract of M. pruriens were shown in Plate 7.
The histological section reveals the presence of atrophy of
seromucous glands with surrounding stromal ﬁbrosis. Plate 8
shows histological section of the breast tissue of DMBA
induced-breast cancer in rats treated with 300 mg/g b wt of
aqueous leaf extract of M. pruriens. The histological section
reveals the presence of atrophy of glands, within surrounding
fatty tissue at a magniﬁcation of 100.
Plate 9 shows the DNA fragmentation images for the con-
trol groups (NC and PC) and the treatment groups (WA, WB,
WC and WD) obtained by single cell gel electrophoresis and
Table 4 shows qualitative and quantitative analytical results
of DNA fragmentation images obtained by single cell gel elec-
trophoresis. The % DNA in tail, tail moment and tail length in
the control and treatment groups were shown to be NC
(50.13%, 9.35, 41), PC (0.25%, 0, 0), WA (31.26%, 4.99,
27), WB (18.59%, 2.14, 21), WC (12.48%, 1.15, 10) and WD
(3.37%, 0.06, 2) respectively.
5. Discussion
Breast cancer is the commonest female cancer and most com-
mon cancer in both sexes [39]. Breast cancer is a kind of cancer
that develops from breast cells. It is the most common type of
cancer among women in Nigeria [40]. A major obstacle for
cancer therapies is lack of targeted delivery of therapeutics.
Therefore, there is a dire need to better understand the mech-
anisms by which drug resistance develops and to design new
combined treatments that beneﬁt patients [41]. To compensate,
existing drug treatments rely on high dosages and frequent
administrations. This results in adverse effects in the patient
due to the drugs failure to discriminate between normal body
cells and tumor cells [42]. Cancer chemoprevention involves
the chronic administration of a synthetic, natural or biological
agent to reduce or delay the occurrence of malignancy. The
potential value of this approach has been demonstrated with
trials in breast, prostate and colon cancer [16]. However, it is
likely that many agents, particularly those that are dietary
derived and multi-targeted, will have effects throughout the
carcinogenic process [43]. Compounds that inhibit cancer initi-
ation are traditionally termed ‘blocking agents’. They may act
Figure 1 Effects of different concentrations of aqueous extract
of Mucuna pruriens leaf on the survival rate of DMBA induced-
breast cancer in rats.
Normocellular serous glands
Plate 3 Histological section of the breast tissue of DMBA-
induced breast cancer in rats from PC (HE-100). (Normocellular
serous glands.)
Atrophy of seromucous glands 
with surrounding stromal 
Plate 4 Histological section of the breast tissue of DMBA-
induced breast cancer in rats from NC (HE-100). (Atrophy of
seromucous glands with surrounding stromal ﬁbrosis.)
Isolated Tumor Length
Plate 2 Length of isolated tumor of DMBA-induced rats only.
(From the neck region.)
Hyperplasia of serous and 
mucinous glands
Plate 5 Histological section of the breast tissue of DMBA-
induced breast cancer in rats from WA (HE-100). (Hyperplasia
of serous and mucinous glands.)
 
Atrophy of glands with 
periductal stromal fibrosis and 
fatty tissue 
Plate 6 Histological section of the breast tissue of DMBA-
induced breast cancer in rats from WB (HE-100). (Atrophy of
glands with periductal stromal ﬁbrosis and fatty tissue.)
336 J.B. Minari et al.
Atrophy of seromucous glands 
with surrounding stromal 
fibrosis
Plate 7 Histological section of the breast tissue of DMBA-
induced breast cancer in rats from WC (HE-100). (Atrophy of
seromucous glands with surrounding stromal ﬁbrosis.)
Atrophy of glands, within 
surrounding fatty tissue
Plate 8 Histological section of the breast tissue of DMBA-
induced breast cancer in rats from WD (HE-100). (Atrophy of
glands, within surrounding fatty tissue.)
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endogenous free radicals and DNA, thereby reducing the level
of damage and resulting mutations which contribute not only
to cancer initiation but also progressive genomic instability
and overall neoplastic transformation. Protection may be
achieved as a consequence of decreased cellular uptake and
metabolic activation of pro-carcinogens and/or enhanced
detoxiﬁcation of reactive electrophiles and free radical scav-
enging, as well as induction of repair pathways [43,44]. Owing
to this development, ‘Theanti-proliferative potential ofaqueous
leaf extract ofMucuna pruriens on DMBA-inducedbreast can-
cer in female albino rats’ was evaluated. Henry and Narendra
[45] reported that numerous studies have shown that 7,12-
dimethylbenz(a)anthracene (DMBA) can be used to induce
experimental breast carcinomas in rats and that this process
involves disruption of tissue redox balance; in turn, this sug-
gests that biochemical and pathophysiological disturbances
may result from oxidative damage.
Medicinal plants contain some organic compounds which
provide deﬁnite physiological action on the human body and
these bioactive substances include tannins, alkaloids, carbohy-
drates, terpenoids, steroids and ﬂavonoids [46]. Thesecompounds are synthesized by primary or rather secondary
metabolism of living organisms. Secondary metabolites are
chemically and taxonomically extremely diverse compounds
with obscure function. They are widely used in the human
therapy, veterinary, agriculture, scientiﬁc research and count-
less other areas [47]. Knowledge of the chemical constituents
of plants is desirable because such information will be value
for synthesis of complex chemical substances [48]. They pos-
sess biological properties such as antiapoptosis, antiaging,
anticarcinogen, anti-inﬂammation, antiatherosclerosis, cardio-
vascular protection and improvement of endothelial function,
as well as inhibition of angiogenesis and cell proliferation
activities [49]. In this sense chemopreventive phytochemicals
are applicable to cancer therapy, since molecular mechanisms
may be common to both chemoprevention and cancer therapy
[50,51].
Phytochemical analysis of the result presented in this study
conﬁrm the presence of constituents such as alkaloids, reduc-
ing sugar, anthraquinones, ﬂavonoids, saponins, tannins, car-
diac glycosides, phenols and steroids (Table 1); which are
known to exhibit remarkable medicinal as well as physiological
activities showing speciﬁc mode of action. This is in agreement
with the study review of Sherma et al. [52] on the phyto con-
stituents and therapeutic uses on M. pruriens. However, the
presence of alkaloid and absence of terpenoid contradicts the
result of Agbafor and Nwachukwu [53] who reported the
absence of alkaloid and presence of terpenoid. This could be
prior to the fact that the location of the plant might be a sig-
niﬁcant factor in determining the presence or absence of essen-
tial phytoconstituents; other contributing factors that might
also play a major role are the biosynthetic mechanism, envi-
ronmental factors and interaction with micro or macro ele-
ments. The quantitative phytochemical screening of selected
phytochemicals present in the aqueous extract of M. pruriens
is shown in (Table 2). Flavonoid was found to be present in
the highest amount (21.14%) while alkaloid was found to be
in the lowest amount (0.35%). The relatively high amount of
ﬂavonoid (an antioxidants/free radical scavenger) could possi-
bly be responsible for the signiﬁcant reduction (p< 0.05) in
weight and inhibition of tumorigenesis in rats administered
with 300 mg/g b wt (WD). Many forms of cancer are the result
of reactions between free radicals and DNA, resulting in muta-
tions that can lead to malignancy. Free radicals and their
metabolites are increasingly recognized for their contribution
to tissue injury leading to both initiation and promotion of
multistage carcinogenesis [54,55]. According to Slaga [54],
antioxidants/free radical scavengers function as inhibitors of
both tumor initiation and promotion. Flavonoids are simple
phenolic compounds which have been reported to possess a
wide spectrum of biochemical activities such as antioxidant,
antimutagenic, anticarcinogenic, as well as ability to modify
the gene expression [56,57].
In general, the mechanism of action is considered to be the
disturbance of the cytoplasmic membrane, disrupting the pro-
ton motive force, electron ﬂow, active transport, and coagula-
tion of cell contents [58]. The presence of phenol (2.21%),
relatively confers its potential to also inﬂuence cancer progres-
sion in the breast tissues. Polyphenols particularly are among
the diverse phytochemicals that have the potential in the inhi-
bition of carcinogenesis [59].
The visible evidence of 7,12-dimethylbenz(a)anthracene
administration on DMBA-induced-tumorigenesis was seen at
Image Treatments Comet images
1 NC(Negative control) –DMBA 
Induced rats only
H                  T
2 PC(Positive control)– Control 
experiment
H 
3 WA(DMBA Induced rats treated with 
M. pruriens extract (50 mg/g b wt))
H                 T
4 WB(DMBA Induced rats treated with 
M. pruriens extract (100 mg/g b wt))
H       T
5 WC(DMBA Induced rats treated with 
M. pruriens extract (200 mg/g b wt))
H     T
6 WD(DMBA Induced rats treated with 
M. pruriens extract (300 mg/g b wt))
H  T
Plate 9 DNA fragmentation images obtained by single cell gel electrophoresis.
Table 4 Qualitative and quantitative analytical results of
DNA fragmentation images obtained by single cell gel
electrophoresis (SCGE).
Image % DNA in tail Tail moment Tail length
NC 50.13 9.35 41
PC 0.25 0 0
WA 31.26 4.99 27
WB 18.59 2.14 21
WC 12.48 1.15 10
WD 3.37 0.06 2
% – (Percentage).
NC (Negative control) – DMBA induced rats only.
PC (Positive control) – Control experiment.
WA – DMBA induced rats treated withM. pruriens extract (50 mg/
g b wt).
WB – DMBA induced rats treated with M. pruriens extract
(100 mg/g b wt).
WC – DMBA induced rats treated with M. pruriens extract
(200 mg/g b wt).
WD – DMBA induced rats treated with M. pruriens extract
(300 mg/g b wt).
338 J.B. Minari et al.the neck region of one of the rats administered with DMBA
only (Plate 1) about 10 weeks after DMBA induction. This
occurred earlier than reported by Amin et al. [60]. This could
be prior to the fact that the modiﬁed protocol of Alfredo et
al. [61] used for this study was of a relatively high concentra-
tion and reason for development of tumor at the neck region
could be due to the spread of the breast cancer cells to thelymph nodes in the chest, under the arm, above or below the
collar bone which are connected to the lymphatic vessels from
the breast. According to the American Cancer Society [62],
most breast cancers begin in the cells that line the ducts (ductal
cancers). Some begin in the cells that line the lobules (lobular
cancers), while a small number start in other tissues. The
lymph system is important to understand because it is one
way breast cancers can spread. Breast cancer cells can enter
lymphatic vessels and begin to grow in lymph nodes. Most
lymphatic vessels in the breast connect to lymph nodes under
the arm (axillary nodes). Some lymphatic vessels connect to
lymph nodes inside the chest (internal mammary nodes) and
those either above or below the collarbone (supraclavicular
or infraclavicular nodes).
Also, the development of tumor at the neck region in the
experimental rat (NC) supports the claims of Clark [63]; Russo
et al. [64] and Balogh et al. [65] that several tissues are capable
of activating DMBA. In a recent study conducted by Minari
and Okeke [66], DMBA-induced-papilloma was seen toward
the hind limbs. The increase in death rate was observed in
the sixth week in the NC group of rats administered with
DMBA only may also be due to the toxicity of the carcinogen.
The signiﬁcant reduction (p< 0.05), in the weight of exper-
imental rats that took 300 mg/g b wt (WD) of the extract when
compared with the positive control is an indication of the pos-
sible toxicity of aqueous extract of M. pruriens leaf suggesting
the possible interaction between phytochemical components
due to increase in concentration (Table 3). This is in agreement
with the work of Ngatchic et al. [67] on toxicity level of M.
pruriens. Kumar and Saha [68] documented in their review that
this plant has no such toxicological consensus but has several
Antiproliferative potential of Mucuna pruriens on DMBA-induced breast cancer 339limitations. It was further stated that it is toxic to humans and
animals due to the presence of 3-(3,4-dihydroxyphenyl)-1-
alanine (L-DOPA) and tryptamines.
The isolated tumor shown in Plate 2 is also a clear indica-
tion of the carcinogenic effect of induced DMBA (a polycyclic
aromatic hydrocarbon) in the experimental rats which sup-
ports the studies of Ko et al. [69] that animal models have
helped demonstrating different classes of chemicals to act as
initiators and induce mammary cancer. Polycyclic aromatic
hydrocarbons (PAHs) are toxic compounds commonly found
in the environment. PAHs are genotoxic and capable of form-
ing carcinogen–DNA adducts in human or animal tissues.
Once these chemicals are consumed, our body will metabolize
and transform these compounds into DNA attacking muta-
gens. Epidemiological studies have revealed that PAHs can
form adducts in humans. Higher amounts of benzyl-[a]-pyrene
like DNA adducts have been found in human breast tumors
than in normal breast tissues. As one of the PAHs, DMBA
has been shown to affect cellular signaling pathways to induce
apoptosis. It is also known to induce cytotoxicity in various
cell types, including mouse epidermis, hepatoma, and
ﬁbroblasts.
In human breast carcinomas, proliferation occurs almost
exclusively in epithelial cells [63–65].
The histopathological classiﬁcation of breast disease is sub-
jective and, despite an attempt to provide clear guidelines, the
inter-observer variability is known to be high [70]. The pres-
ence of DMBA-induced atrophy of seromucous glands with
surrounding stromal ﬁbrosis, hyperplasia of serous and muci-
nous glands, atrophy of glands with periductal stromal ﬁbrosis
and fatty tissue and atrophy of seromucous glands with sur-
rounding stromal ﬁbrosis in the histological sections of breast
tissues of DMBA-induced breast cancer of rats that were
administered with 7,12-dimethylbenz(a)anthracene in (Plates
5–8) respectively suggest that DMBA-induced rat mammary
carcinomas have been shown to arise from the ductal elements
of the mammary gland and signiﬁcant variability in tissues
induced with the carcinogen. This corresponds with the studies
of Chow et al. [71]. The mammary tumors in rats arise in the
epithelium of the terminal end buds, which are comparable
structures to the terminal ductal lobular units in the human
breast [32]. Nicolas et al. [72] in an experimental study con-
ﬁrmed that the most common histologies of the DMBA-
induced mammary tumors were squamous or adenosquamous
carcinomas, accounting for 85% of the mammary tumors,
with other tumors being of the Wnt type, or scirrhous tubular,
spindle cell, or papillary carcinomas.
The single cell gel electrophoresis results as shown in Plate 8
and Table 4 indicates largely the chemopreventive potential of
the leaf extract of M. pruriens on possible DMBA-induced
DNA damage. The % DNA in tail, tail length and moment
of the WB (18.59%, 2.14, 21), WC (12.48%, 1.15, 10) and
WD (3.37%, 0.06, 2) groups respectively were signiﬁcantly
reduced at their respective concentration of the leaf extract
of M. pruriens when compared with the NC (50.13%, 9.35,
41) group; which might be due to the presence of antioxidants
in the plant with the potential to scavenge free radicals and
inhibit oxidative DNA damage by DMBA. Polycyclic aro-
matic hydrocarbons (PAH) such as 7,12-dimethylbenz(a)
anthracene (DMBA) have been shown to form free radicals
and these compounds play a critical role in carcinogenesis
[73]. This role is accompanied by direct interaction withDNA and the generation of reactive oxygen species (ROS),
such as peroxides, hydroxyl and superoxide anion radicals,
which induce cellular oxidative damage through oxidation of
biomolecules such as proteins and nucleo-bases, DNA strand
breaks and lipid peroxidation [74]. Oxidative injury may pro-
duce unrepaired DNA damage and result in the accumulation
of mutations. DNA mutation is a critical step in carcinogene-
sis, and elevated levels of oxidative DNA lesions such as 8-OH-
dG have been noted in various tumors, strongly implicating
such damage in the etiology of cancer [75]. Moreover, natural
antioxidants contained in medicinal and aromatic plants, fruits
and vegetables may be useful in preventing the deleterious con-
sequences of oxidative damage caused by ROS and therefore
they are considered as possible chemopreventive agents. They
can possess a variety of biological activities, e.g., anti-
mutagenic, anti-carcinogenic, anti-proliferative, scavenging of
free radicals or activated mutagens/carcinogens, they can mod-
ulate DNA repair and other enzyme activities or even regulate
gene expression [76,77].
6. Conclusion
The present study showed that the aqueous extract ofM. prur-
iens leaves can be used as an anti-proliferative measure against
DMBA induced breast cancer in female albino rats.
Histological assay revealed the presence of atrophy of sero-
mucous glands with surrounding stromal ﬁbrosis, and hyper-
plasia of serous and mucinous glands which suggest the
presence of cells undergoing initial proliferation stage preced-
ing carcinogenesis.
The knowledge obtained from this study serves as a
resource base and can be scientiﬁcally exploited for future
research in breast cancer chemoprevention. Finally, the pre-
sent study identiﬁes new areas of research for development
of better therapeutic and chemopreventive agents for colon,
lungs and prostate cancer, and other infectious diseases.
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Appendix
Week 1
ANOVA Table SS df MS
Treatment
(between columns)
10,930 5 2187
Residual
(within columns)
23,000 54 425.9
Total 33,930 59
Newman–Keuls
Multiple
Comparison Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 26.38 4.042 Yes **
PC vs WD 14.22 2.180 No ns
PC vs WC 10.62 — No ns
PC vs WB 9.592 — No ns
PC vs WA 3.644 — No ns
J.B. Minari et al.Week 2ANOVA Table SS df MS
Treatment
(between columns)
3486 5 697.1
Residual (within
columns)
600.8 24 25.03
Total 4086 29
Newman–Keuls
Multiple
Comparison Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 5.620 2.512 No ns
PC vs WD 25.28 11.30 Yes ***
PC vs WC 19.28 8.617 Yes ***
PC vs WB 7.680 3.432 No ns
PC vs WA 3.280 — No ns
340Week 3
ANOVA Table SS df MS
Treatment
(between columns)
6824 5 1365
Residual (within
columns)
2214 24 92.25
Total 9038 29
Newman–Keuls
Multiple
Comparison Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
PC vs WD 41.92 9.759 Yes ***
PC vs WC 35.62 8.292 Yes ***
PC vs WB 28.12 6.546 Yes ***
PC vs WA 19.46 4.530 Yes *
PC vs NC 6.040 1.406 No nsWeek 4
ANOVA Table SS df MS
Treatment
(between columns)
8258 5 1652
Residual (within
columns)
10,870 24 452.9
Total 19,130 29
Newman–Keuls
Multiple
Comparison Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 18.46 — No ns
PC vs WC 28.56 3.001 No ns
PC vs WD 28.02 — No ns
PC vs WB 19.06 — No ns
PC vs WA 12.32 — No nsWeek 5
ANOVA Table SS df MS
Treatment
(between columns)
6664 5 1333
Residual
(within columns)
18,950 24 789.7
Total 25,620 29
Newman–Keuls
Multiple Comparison
Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 34.72 — No ns
NC vs WA 33.20 — No ns
WA vs PC 1.520 — No ns
PC vs WD 9.100 — No ns
PC vs WB 7.800 — No ns
PC vs WC 4.340 — No nsWeek 6
ANOVA Table SS df MS
Treatment
(between columns)
4730 5 946.0
Residual
(within columns)
20,500 24 854.3
Total 25,230 29
Newman–Keuls
Multiple Comparison
Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 29.60 — No ns
NC vs WA 27.12 — No ns
WA vs PC 2.480 — No ns
PC vs WD 7.640 — No ns
PC vs WB 6.400 — No ns
PC vs WC 2.340 — No nsWeek 7
ANOVA Table SS df MS
Treatment
(between columns)
4974 5 994.7
Residual
(within columns)
19,160 24 798.1
Total 24,130 29
Newman–Keuls
Multiple Comparison
Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 31.60 — No ns
NC vs WA 31.38 — No ns
PC vs WD 5.420 — No ns
PC vs WB 5.040 — No ns
PC vs WC 1.980 — No ns
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Treatment
(between columns)
11,410 5 2281
Residual
(within columns)
33,260 24 1386
Total 44,670 29
Newman–Keuls
Multiple Comparison
Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 52.64 — No ns
NC vs WA 49.86 — No ns
WB vs PC 2.860 — No ns
WA vs PC 2.780 — No ns
PC vs WD 1.920 — No ns
PC vs WC 1.020 — No nsWeek 9
ANOVA Table SS df MS
Treatment
(between columns)
6833 5 1367
Residual (within
columns)
45,920 24 1913
Total 52,750 29
Newman–Keuls
Multiple
Comparison Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 45.88 2.345 No ns
WC vs PC 9.680 — No ns
WA vs PC 9.100 — No ns
WD vs PC 8.240 — No ns
WD vs WB 3.460 — No ns
WB vs PC 4.780 — No nsWeek 10
ANOVA Table SS df MS
Treatment
(between columns)
10,930 5 2187
Residual (within
columns)
23,000 54 425.9
Total 33,930 59
Newman–Keuls
Multiple
Comparison Test
Mean
Diﬀ.
q Signiﬁcant?
P< 0.05?
Summary
NC vs PC 26.38 4.042 Yes **
PC vs WD 14.22 2.180 No ns
PC vs WC 10.62 — No ns
PC vs WB 9.592 — No ns
PC vs WA 3.644 — No nsReferences
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